AN INGENIOUS PLAN
Our mission was simple: to create the most effective collagen supplement on the market that was good for both you and the planet
An Ingenious Truth
We believe that good science needs integrity to become great science. To become great, we therefore consider in all our processes: sustainability, responsibility, and wellbeing. Our Ingenious packaging is fully recyclable and uses as little plastic as possible, while our recyclable eco-pouches encourage good habits and minimise our carbon footprint.
Our protected collagen is sourced from the skin of free-swimming Tilapia fish. All our natural astaxanthin is from micro-algae sourced exclusively from a pristine archipelago in Sweden. Our supplements are as pure as they are potent. We have no additives, fillers, binding agents, flow agents, preservatives or any other anti-nutrient. As a result, our capsules are hand-filled in small batches as we will not compromise on our ethos to ensure you are putting only the best and most effective actives inside your body.
Our new-generation collagen supplements use patented technology to ensure maximum absorption of the finest, most sustainably sourced, bio-available ingredients: marine collagen peptides, natural astaxanthin and the latest innovation in multi-molecular hyaluronic acid which is 20 per cent more effective than standard HA.
At Ingenious we believe in combining science and sustainability for the wellbeing of our customers and the planet.
in the UK
Our KEY PEOPLE
David Hyland CEng MSc MBA
Founder and Head of Product Development
PUPINDER GHATORA MPharm MRPharmS SCS
Founder and CEO
PROF. LUIGI G MARTINI FRPharmS, FRSC, MBA
Director of Science
An Industrial Pharmacist and a Fellow of the Royal Pharmaceutical Society, Professor Martini divides his time between Industry and King’s College London where he is a Visiting Professor in Pharmaceutical Innovation, having held the Chair in Pharmaceutical Innovation at King’s for 5 years. Prior to his tenure in Academia, Professor Martini spent over 17 years at GlaxoSmithKline Pharmaceuticals, Roche Products Ltd. and Shire Pharmaceuticals, working in a variety of Technical, Commercial, Innovation based and Medical Affairs roles, directing groups in the US, Europe and Emerging Markets. Professor Martini is past Chair of the Industrial Pharmacists Group of the Royal Pharmaceutical Society and past President of the European Industrial Pharmacists Group. In 2016, Professor Martini was appointed a Fellow of the European Industrial Pharmacists Group. Read more about Prof. Martini’s story.